Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Leonard Chapman
CEOStephen Leonard Chapman
Employees
6,140
Employees6,140
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
6,140
Employees6,140

NTRA Key Statistics

Market cap
31.01B
Market cap31.01B
Price-Earnings ratio
-131.91
Price-Earnings ratio-131.91
Dividend yield
Dividend yield
Average volume
1.40M
Average volume1.40M
High today
$226.00
High today$226.00
Low today
$215.51
Low today$215.51
Open price
$221.66
Open price$221.66
Volume
1.02M
Volume1.02M
52 Week high
$256.36
52 Week high$256.36
52 Week low
$131.81
52 Week low$131.81

Stock Snapshot

The current Natera(NTRA) stock price is $216.50, with a market capitalization of 31.01B. The stock trades at a price-to-earnings (P/E) ratio of -131.91.

On 2026-06-10, Natera(NTRA) stock traded between a low of $215.51 and a high of $226.00. Shares are currently priced at $216.50, which is +0.5% above the low and -4.2% below the high.

Natera(NTRA) shares are trading with a volume of 1.02M, against a daily average of 1.4M.

In the last year, Natera(NTRA) shares hit a 52-week high of $256.36 and a 52-week low of $131.81.

In the last year, Natera(NTRA) shares hit a 52-week high of $256.36 and a 52-week low of $131.81.

NTRA News

Simply Wall St 2d
Have Natera Insiders Been Selling Stock?

Some Natera, Inc. ( ) shareholders may be a little concerned to see that the Lead Independent Director, Roelof Botha, recently sold a substantial US$17m worth o...

Have Natera Insiders Been Selling Stock?
Simply Wall St 3d
How Investors May Respond To Natera Expanding Signatera MRD Reach Amid Insider Share Sale

In recent weeks, Natera, Inc. has expanded its oncology and women’s health footprint through new collaborations using its Signatera MRD platform in metastatic c...

How Investors May Respond To Natera Expanding Signatera MRD Reach Amid Insider Share Sale
TipRanks 5d
Natera Expands Board, Appoints Thomas Lynch as Director

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

86%

of 21 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More NTRA News

TipRanks 6d
Natera initiated with a Neutral at Goldman Sachs

Goldman Sachs analyst Evie Koslosky initiated coverage of Natera (NTRA) with a Neutral rating and $245 price target The firm views Natera as the current leader...

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.